USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Exfo Inc.

USPTO PatentsView assignee record - 114 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01M (Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR).

RSS updates for this company

The verdict

According to USPTO PatentsView, Exfo ranks #3,278 of 49,997 tracked US assignees by granted-patent volume, with 114 patents across 21 technology areas.

#3,278
of 49,997 US assignees by volume
Top 16%
by Innovation Score (48.5/100)
15.1
avg claims per patent
+4%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3278 · Foreign Corporation #3,278 · 114 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-MID 114 grants
  • TOP-DECILE #3,278/49,997
  • PHOTO-FINISH Chia Tai Tianqing…
  • CPC-FOCUS G01M · 21 areas
  • INNOV-PAR 48.5/100
  • CLAIMS-RICH 15.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT +4% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Exfo

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Exfo's Innovation Score is 48.5/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Exfo's grants concentrate

Exfo Inc. is a focused PatentsView assignee: 21 CPC subclasses with 41.2% of grants classified under G01M (Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR). Peak complete grant year is 2017 (18 grants) versus a trough of 7 in 2015. By volume, Exfo sits between Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Janssen Vaccines & Prevention B.V..

Exfo's three-year grant acceleration

From 2019–2021 to 2022–2024, Exfo Inc. moved from 32 to 33 grants (1.03x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,101. See the growth leaderboard.

Who files at Exfo's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Exfo holds 114 patents at rank #3,278, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Exfo

By rank, the assignees closest to #3,278 in granted patent volume.

Leaders in G01M (Testing Static OR Dynamic Balance OF Machines OR Structures)

Other assignees with the most granted patents in Exfo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Exfo, neither rank-band nor same-CPC leaders (those blocks stay above).

Exfo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Exfo Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 7 6.1%
2016 11 9.6%
2017 18 15.8%
2018 9 7.9%
2019 9 7.9%
2020 9 7.9%
2021 14 12.3%
2022 16 14.0%
2023 7 6.1%
2024 10 8.8%
2025partial year 4 3.5%

Where it ranks

Overall rank by patents

#3,278

of 49,997 tracked assignees

Innovation Score

48.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Exfo Inc.'s patent record in context - here's where to go next.

  • Exfo Inc.'s lead technology class is G01M (Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR), 41.2% of its portfolio - see every assignee active in that class. Explore G01M
  • Ranked #3,278 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Exfo Inc. against Chia Tai Tianqing Pharmaceutical Group Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 48.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.